PAS1C1 Antikörper (Middle Region)
Kurzübersicht für PAS1C1 Antikörper (Middle Region) (ABIN1450045)
Target
Alle PAS1C1 (IFLTD1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human, Mouse, Rat.
-
Aufreinigung
- Affinity chromatography purified via peptide column
-
Immunogen
- 19 amino acid synthetic peptide near the center of Human IFLTD1
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- PAS1C1 (IFLTD1) (Intermediate Filament Tail Domain Containing 1 (IFLTD1))
-
Andere Bezeichnung
- IFLTD1
-
Hintergrund
- The intermediate filament tail domain-containing protein (IFLTD1) was initially identified as a candidate gene for pulmonary adenoma susceptibility 1 gene in mice. Transcripts of the gene were only detected in mouse lung tissue from strains carrying the Pas1-susceptible allele. Expression of different alleles of this gene in lung cancer cell lines resulted in different levels of colony formation in in vitro colony formation assays, suggesting that allelic variants of this gene can modulate growth of human cancer cells.Synonyms: Intermediate filament tail domain-containing protein 1
-
Gen-ID
- 160492
-
NCBI Accession
- NP_001139200
Target
-